Skip to content
Catalyst

PapersPMID:31249528

The Effects of Curcumin on Weight Loss Among Patients With Metabolic Syndrome and Related Disorders: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Frontiers in pharmacology2019The record ↗

findings
3
compound
1
endpoints
3
PMID:31249528
  1. Finding, moderate evidencelowersSerum leptin
  2. Finding, moderate evidencelowersBody mass index
  3. Finding, moderate evidencelowersBody mass
Study, every finding
meta-analysis
  • Decreases serum leptin

    moderatereplicated ×3

    “The results showed that curcumin intake among individuals with metabolic diseases significantly reduced leptin (SMD −0.97; 95% CI, −1.18, −0.75; P < 0.001) and increased adiponectin levels (SMD 1.05; 95% CI, 0.23, 1.87; P = 0.01).”
    Effect
    −0.97 standardised mean difference, 95% CI −1.18 to −0.75
    Population
    individuals with metabolic diseases, compared to placebo (pooled meta-analysis)
  • “Curcumin resulted a significant reduction in BMI (SMD −0.37; 95% CI, −0.61, −0.13; P < 0.01), weight (SMD −0.23; 95% CI, −0.39, −0.06; P < 0.01), and WC levels (SMD −0.25; 95% CI, −0.44, −0.05; P = 0.01).”
    • Decreases body mass index

      moderatereplicated ×8

      Effect
      −0.37 standardised mean difference, 95% CI −0.61 to −0.13
      Population
      patients with metabolic syndrome and related disorders, compared to placebo (pooled random-effects meta-analysis)
    • Decreases body mass

      moderatereplicated ×3

      Effect
      −0.23 standardised mean difference, 95% CI −0.39 to −0.06
      Population
      patients with metabolic syndrome and related disorders, compared to placebo (pooled random-effects meta-analysis)

Study record

Design
meta-analysis
Species
human
Population
patients with metabolic syndrome and related disorders
Participants
1,646
Comparator
placebo
Duration
not reported
Endpoints measured
30